Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
100%(6 trials)

Phase Distribution

Ph phase_1
2
33%
Ph phase_2
4
67%

Phase Distribution

2

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
4(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (33.3%)
Phase 24 (66.7%)

Trials by Status

completed6100%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_2

A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma

NCT00490451
completedphase_1

Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia

NCT00718159
completedphase_1

Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid Tumors

NCT01214668
completedphase_2

Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer

NCT00363766
completedphase_2

A Study of LY573636-sodium in Patients With Metastatic Breast Cancer

NCT00992225
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00490451Phase 2

A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma

Completed
NCT00718159Phase 1

Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia

Completed
NCT01214668Phase 1

Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid Tumors

Completed
NCT00363766Phase 2

Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer

Completed
NCT00992225Phase 2

A Study of LY573636-sodium in Patients With Metastatic Breast Cancer

Completed
NCT00428610Phase 2

A Study of Chemotherapy Treatment for Patients With Ovarian Cancer

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6